Published: Headache: The Journal of Head and Face Pain, December 2025 (presented at American Headache Society Annual Meeting 2025)
Researchers: Nathaniel Schuster et al. — UC San Diego — 92 participants, 247 migraine attacks treated
1. What Was Studied?
This was the first randomized, double-blind, placebo-controlled trial ever conducted on vaporized cannabis for acute migraine. Migraine is one of the most common reasons people use cannabis, yet until this trial it had never been rigorously tested in a controlled setting.
92 adults with a history of migraine were enrolled and each treated up to four separate migraine attacks — one with THC-dominant cannabis, one with CBD-dominant cannabis, one with a THC/CBD combination, and one with placebo cannabis flower. They used a vaporizer during an actual migraine attack, at home, and reported outcomes at two, 24 and 48 hours.
2. What Did They Find?
The THC/CBD combination (6% THC + 11% CBD) was significantly superior to placebo for pain relief at two hours — 67.2% achieved pain relief versus 46.6% with placebo
Pain freedom at two hours was reached by 34.5% with THC/CBD versus 15.5% with placebo — more than double the rate
Benefits were sustained at 24 and 48 hours — the effects didn't just wear off quickly
Freedom from the most bothersome migraine symptoms (light sensitivity, sound sensitivity) was also significantly better with THC/CBD
THC alone improved pain relief but didn't consistently outperform placebo on the key secondary measures
CBD alone did not significantly outperform placebo for any primary outcome
No serious adverse events were reported
3. What This Means
For the millions of people who use cannabis during a migraine attack — this study finally puts some real clinical data behind that practice. The THC/CBD combination showing roughly double the pain freedom rate of placebo is a meaningful finding, not a marginal one.
The finding that CBD alone didn't outperform placebo is also important. A lot of people reach for CBD specifically for migraines — this trial suggests that THC, or the combination, is where the effect lives. That's a useful distinction for anyone trying to make informed decisions about what to use.
4. What This Does NOT Mean
This was a crossover trial — each participant treated multiple attacks, which improves data quality but means the sample is smaller than it appears
The cannabis flower used came from a research supply programme and may not match consumer products in terpene content or cannabinoid ratios
Results apply to acute migraine treatment — not prevention
Cannabis is not currently a recommended first-line treatment for migraine
People on prescription migraine medications should speak to their doctor before adding cannabis
5. Bottom Line
The first placebo-controlled trial of vaporized cannabis for acute migraine found the THC/CBD combination more than doubled pain freedom rates versus placebo — with benefits lasting up to 48 hours and no serious adverse events.
🗣️ Mary Jane's Take
Migraine is one of the most common reasons people use cannabis and one of the least studied. This trial finally asks the question properly. CBD alone didn't do much — it was the combination that worked. That's worth knowing if you're reaching for a pure CBD product during a migraine.
